107 related articles for article (PubMed ID: 27556829)
1. Association of Part D coverage gap with COPD medication adherence.
Yu YF; Hearld LR; Qu H; Ray MN; Kilgore ML
Am J Manag Care; 2016 Aug; 22(8):e275-82. PubMed ID: 27556829
[TBL] [Abstract][Full Text] [Related]
2. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a drug adherence index for COPD.
Bengtson LGS; Bancroft T; Schilling C; Buikema AR; Stanford RH
J Manag Care Spec Pharm; 2021 Feb; 27(2):198-209. PubMed ID: 33506734
[No Abstract] [Full Text] [Related]
4. Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.
Bishwakarma R; Zhang W; Kuo YF; Sharma G
Int J Chron Obstruct Pulmon Dis; 2017; 12():477-486. PubMed ID: 28203071
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
6. Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.
Albrecht JS; Park Y; Hur P; Huang TY; Harris I; Netzer G; Lehmann SW; Langenberg P; Khokhar B; Wei YJ; Moyo P; Simoni-Wastila L
Ann Am Thorac Soc; 2016 Sep; 13(9):1497-504. PubMed ID: 27332765
[TBL] [Abstract][Full Text] [Related]
7. Part D coverage gap and adherence to diabetes medications.
Gu Q; Zeng F; Patel BV; Tripoli LC
Am J Manag Care; 2010; 16(12):911-8. PubMed ID: 21348561
[TBL] [Abstract][Full Text] [Related]
8. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
[TBL] [Abstract][Full Text] [Related]
9. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
[TBL] [Abstract][Full Text] [Related]
10. Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.
Qian J; Simoni-Wastila L; Rattinger GB; Zuckerman IH; Lehmann S; Wei YJ; Stuart B
Int J Geriatr Psychiatry; 2014 Jan; 29(1):49-57. PubMed ID: 23606418
[TBL] [Abstract][Full Text] [Related]
11. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers.
Yu AP; Guérin A; Ponce de Leon D; Ramakrishnan K; Wu EQ; Mocarski M; Blum S; Setyawan J
J Med Econ; 2011; 14(4):486-96. PubMed ID: 21679019
[TBL] [Abstract][Full Text] [Related]
12. Effects of coverage gap reform on adherence to diabetes medications.
Zeng F; Patel BV; Brunetti L
Am J Manag Care; 2013 Apr; 19(4):308-16. PubMed ID: 23725362
[TBL] [Abstract][Full Text] [Related]
13. Increasing Medicare part D enrollment in medication therapy management could improve health and lower costs.
Stuart B; Loh FE; Roberto P; Miller LM
Health Aff (Millwood); 2013 Jul; 32(7):1212-20. PubMed ID: 23836736
[TBL] [Abstract][Full Text] [Related]
14. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
15. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
[TBL] [Abstract][Full Text] [Related]
16. Effects of Medicare Part D coverage gap on medication adherence.
Zhang Y; Baik SH; Lave JR
Am J Manag Care; 2013 Jun; 19(6):e214-24. PubMed ID: 23844750
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Entering the Prescription Drug Coverage Gap Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.
Xu Q; Laxa SS; Serna O; Sansgiry SS
Popul Health Manag; 2021 Apr; 24(2):241-248. PubMed ID: 32343925
[TBL] [Abstract][Full Text] [Related]
18. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
Polinski JM; Shrank WH; Huskamp HA; Glynn RJ; Liberman JN; Schneeweiss S
PLoS Med; 2011 Aug; 8(8):e1001075. PubMed ID: 21857811
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Cost Sharing on Adherence to Medications Prescribed for Concurrent Use: Do Definitions Matter?
Sacks NC; Burgess JF; Cabral HJ; McDonnell ME; Pizer SD
J Manag Care Spec Pharm; 2015 Aug; 21(8):678-87. PubMed ID: 26233540
[TBL] [Abstract][Full Text] [Related]
20. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
Mueller S; Wilke T; Bechtel B; Punekar YS; Mitzner K; Virchow JC
Respir Med; 2017 Jan; 122():1-11. PubMed ID: 27993284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
